clinical trial · NCT06511076
A Study to Evaluate Zilucoplan Injected Subcutaneously Either by a Prefilled Syringe or an Auto-injector in Healthy Adult Participants
UCB Biopharma SRL·phase1·completed·n = 14
Healthy VolunteersZilucoplan
brief summary
The purpose of this study is to assess the bioequivalence pharmacokinetics, safety, tolerability and device deficiencies of zilucoplan (ZLP) in healthy adult participants
started
Aug 5, 2024
primary completion
Nov 26, 2024
completion
Nov 26, 2024
last updated
Jan 6, 2026
official title
An Open-Label, Single Center, Randomized, 2-Way Crossover, Single-Dose, Bioequivalence Study of Zilucoplan Injected Subcutaneously Either by a Prefilled Syringe or an Auto-Injector in Healthy Adult Participants
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol